Duration: (29:17) ?Subscribe5835 2025-02-13T16:52:18+00:00
Healthcare sector poised for rebound in 2025
(5:22)
GSK Stock Technical Analysis (18/01/25)
(6:51)
Is GlaxoSmithKline a Top Pharma Stock? | $GSK Stock Analysis
(11:24)
Why GSK Stands Out as a Top Biotech Stock to Invest In!
(5:47)
GSK Q4 Earnings: Revenue \u0026 EPS Beat, $2.5B Buyback, \u0026 Long-Term Forecast Boost
(1:51)
Final Trades: Oracle, Vertiv Holdings and GSK
(19)
Is GSK PLC Stock a Buy Now in 2024? | GlaxoSmithKline PLC (GSK) UK Stock Analysis | Full Valuation
(9:30)
GSK beats on top and bottom lines after strong launch of RSV vaccine
(1:24)
BAKED MEAT WITH VEGETABLES AND PEARS
(3:11:24)
Master Trades in Volatile Markets With This 4 MA Strategy
(22:16)
CPI release. Gold's rally. Mean reversion in stock-gold ratio.
(16:52)
Turing CEO Martin Shkreli Talks 5,000% Drug Price Hike (Full Interview) | CNBC
(6:17)
Jim Cramer takes the pulse of the healthcare industry at JPMorgan's healthcare conference
(9:4)
A signal of change
(1:49)
Welcome to the Global Capability Center: our new site in Bengaluru
(2:26)
Anurita Chopra, Head of Marketing, India Sub Continent, Haleon at #PitchBrandTalk2022
(19:1econd)
Chemical Space: Opportunities Amid Tariff Changes, Mayuresh Joshi's Top Picks From This Sector
(18:32)
Is GSK Stock a Buy Now!? | GSK Stock Analysis Deep Dive! |
(15:40)
Is GlaxoSmithKline a Buy Now!? | GSK Stock Analysis
(5:28)
Get Paid Dividends Every Month From Just 3 UK Companies
(5:53)
The setup on key earnings this week: Visa, GSK and XPO
(2:44)
Is GSK an Excellent Dividend Stock to Buy for Passive Income Investors | Dividend Stock Investing
(4:59)
RFK Jr.'s Impact on Healthcare Policy: Investors Weigh Risks and Opportunities
(6:56)
GSK Demerger Explained
(9:49)
GlaxoSmithKline ($GSK) - Quick Stock Analysis
(6:46)
Market will decide valuation of company, says Haleon CEO
(3:13)
GSK Stock pick of the day #investment #passiveincome #stockmarket #investing #stocks #finance
(14:52)
GSK CEO Emma Walmsley on beating Q4 earnings
(4:47)
Is GSK Stock a Buy Now!? | GSK Stock Analysis! |
(12:17)